Page 72 - PARVEEN, S
P. 72

therapy of Hepatitis B virus (HBV) infection. The    imparting agents. It is evident from the result that
             researchers have analyzed the quantity of  HBV-      lag time increases with the increase in percentage
             DNA during lamivudine therapy  and  investigated     of  viscosity  imparting  agent. There is less or no
             the relationship of lamivudine resistance  to        effect of change of concentration of acacia on the
             mutation  type.  Ninety-one hepatitis B patients     lag time. After lag time drug  release  from  the
             were  enrolled  in the study where Real Time         suppositories showed a linear fashion. It was found
             Polymerase  Chain  Reaction (PCR) did estimation     that the release rate  decreases when dissolution
             of  HBV  DNA  and mutation was analyzed by           medium contains high percentage of Xanthan gum
             sequence  detection via PCR, HBV, DNA was            and also sodium carboxy  methyl  cellulose.
             detected  in the serum of 96.7%  (88/91) Patients    However in case of incorporation of HPMC  into
             with mean viral load ranging  from  1×10 to 1×16     the dissolution medium, release rate decreased up
             More than 80% Patients responded to and 17.3%        to 0.2% HPMC, but with 0.3% HPMC the release
             patients showed resistance to lamivudine therapy.    rate increased. Inclusion of different perccntage of
             All lamivudine resistant patients had HBV YMDD       acacia  into the dissolution medium has not
             mutation of eithe 180M/M 204V or rtL180/M2041        significantly changed the release of acetaminophen
             types. PCR based analysis of HBV  DNA and            from suppositories.
             sequence basd mutation detection  can  be
             practically, feasible approach in  Bangladesh  to    223  AKBOR, M.M.; SULTANA, R.;
             monitor hepatitis B patients under lamivudine        ULLAH, A.; HASNAT, A.(Dept. of  Clinical
             therapy.                                             Pharmacy and Pharmacology, Dhaka  University,
                                                                  Dhaka);     AZAD,       M.A.K.;(Dept.      of
             222  AKANDA, M.K.; ISLAM, S.M.A.;                    Pharmaceutical  Technology, Dhaka University,
             CHOWDHURY, J.A. (Dept. of Pharmacy, Asia             Dhaka)  & LATIF, A.H.M.M.  (Institute of
             Pacific Univsrsity, Dhaka)  & REZA, M.S.             Statistical  Reseasch  and  Training,  Dhaka
             (Faculty of Pharmacy, Dhaka University, Dhaka).      University, Dhaka). IN VITRO-IN  VIVO
             EFFECT OF VISCOSITY IMPARTING AGENTS                 CORRELATION  (IVIVC) OF IMMEDIATE
             ON  IN VITRO  DRUG RELEASE FROM PEG                  RELEASE (IR) LEVOFLOXACIN TABLET.
             BASED SUPPOSITORIES. Dhaka Univ.J. Pharm.            Dhaka Univ. J. Pharm. Sci., 2007, 6(2), 113-119.
             Sci., 2005, 4 (1), 1-5.
                                                                  The aim of this study was to examine the in vitro -
             Acetaminophen    loaded   suppositories  were        in vivo  correlation (1VIVC) of two immediate
             prepared and the effects  of  viscosity  imparting   release formulations of levofloxacin 250  mg  film
             agents  on  drug release were investigated.          coated tablet.  In vitro  release  data were obtained
             Suppositories containing 125 mg of acetaminophen     for  each  formulation  by using the USP apparatus
             were prepared by fusion method using PEG 4000        II, in 0.IN HCI of pH 2.0. Twelve healthy subjects
             and PEG 1500 as hydrophilic base.  In vitro          were randomly chosen for  in vivo  study. Blood
             dissolution studies were carried out  by  a  thermal   samples were collected over 24 hour period and
             shaker  with a shaking speed of 90 rpm at a          analysed  by  validated HPLC method with UV
                                   0
             temperature of 37 ± 0.5 C in phosphate buffer of     detection to establish a correlation between in vitro
             pH 6.8. The effect of viscosity imparting agents on   release and  in vivo  absorption.  f 2 and  f 1  were
             the drug release into  phosphate  buffer  were       determined for the time intervals of 5, 10,
             investigated by adding 0.1, 0.2 and 0,3% Xanthan     15,20,25, 30, 45 and 60 minutes and the obtained
             gum,  sodium carboxy methyl cellulose, acacia        values were 65.72, 77.38,  61.93,  53.75,  55.36,
             hydroxyl  propyl methyl cellulose 15 cps and 50      58.59, 60.23 and 61.16 percent for  f 2  and 11.00,
             cps.In vitro release data showed that drug release   4.35, 8.30, 12.15, 5.59, 1.82, 0.06 and 0.11 percent
             was linear in phosphate buffer. After incorporation   for f 1 at respective time intervals. Mean dissolution
             of  viscosity  imparting agent phosphate bufter a    times (MDT) for local and reference products were
             biphasis drug release profile i.e. initial lag phase   obtained  at  7.69 and 9.55 minutes respectively.
             followed by linear phase was observed. Lag time      The values of mean absorption time (MAT) were
             depends on nature and concentration of viscosity     obtained  at 8.27 and 27.96 minutes for local and



                                                             65
   67   68   69   70   71   72   73   74   75   76   77